Bioventix plc
(“Bioventix” or the “Company”)
Result of AGM
Bioventix plc (AIM: BVXP) announces that at its Annual General Meeting (“AGM”), all resolutions put to shareholders were duly passed.
Bioventix plc (BVXP) was notified on 25 October 2019 of the following transaction in its ordinary shares of 5 pence each (“Ordinary Shares”). (more…)
Bioventix plc (BVXP) announces its audited results for the year ended 30 June 2019. (more…)
TR-1: Notification of major interest in shares. To download this report as a PDF file click here.
Bioventix plc (BVXP), a UK company specialising in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, announces that it will release its preliminary results for the year ended 30 June 2019 on 21 October 2019.
TR-1: Notification of major interest in shares. To download this report as a PDF file click here.
TR-1: Notification of major interest in shares. To download this report as a PDF file click here.
TR-1: Notification of major interest in shares. To download this report as a PDF file click here.